Brovana 15 mcg (arformoterol tartrate) Inhalation Solution

About BROVANA

Register for Newsletter

About BROVANA

BROVANA^®: A long-lasting nebulized medicine for COPD

BROVANA^® (arformoterol tartrate) Inhalation Solution is a nebulized long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease (COPD).¹ It's designed to be used in a nebulizer, allowing you to breathe normally to get the dose of medication.¹ BROVANA is taken only twice daily for the long-term maintenance treatment of bronchoconstriction (tightening of the airways) in patients with COPD, including chronic bronchitis and emphysema.¹

Please click here for Important Safety Information.

Picture of BROVANA Box and Nebulizer

How BROVANA Can Help

BROVANA (arformoterol tartrate) Inhalation Solution is a medication that can help you manage COPD symptoms.¹

How to Use BROVANA

A step-by-step explanation of how BROVANA is used.

The Science of BROVANA

Learn how BROVANA works within your body to manage COPD symptoms.

Patient Medication Guide

Prescribing Information

Download the package insert (PI) for BROVANA.

References:
1. BROVANA Medication Guide. Marlborough, MA: Sepracor Inc.; 2006.

Two gentlement enjoying a barbecue

BROVANA is a medicine called a long-acting beta₂-agonist or LABA. BROVANA is used long term, twice a day (morning and evening), in controlling symptoms of chronic obstructive pulmonary disease (COPD) in adults with COPD. BROVANA is for inhalation use only through a standard jet nebulizer connected to an air compressor and should not be swallowed or injected. BROVANA should not be used in children.

BROVANA IMPORTANT PATIENT INFORMATION

In patients with asthma, LABA medicines such as BROVANA may increase the chance of asthma-related death from asthma problems. It is not known if LABA medicines, such as BROVANA, increase the chance of death in patients with COPD. BROVANA does not relieve sudden symptoms of COPD and should not be used more than twice a day. Always have a short-acting beta₂-agonist with you to treat sudden symptoms. Get emergency medical care if breathing problems worsen quickly or you use you short-acting beta₂-agonist medicine but it does not relieve your breathing problems. Do not stop using BROVANA unless told to do so by your healthcare provider because your symptoms might get worse. When you are using BROVANA twice a day, do not use other medicines that contain a LABA for any reason.

Tell your doctor if you have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate or changes in heart rhythm. In COPD clinical trials, the most common adverse events reported with BROVANA were pain, chest pain, back pain, diarrhea, and sinusitis. Other possible side effects include headache, tremor, nervousness, and dizziness.

For additional information, please see the Complete Prescribing Information and Medication Guide for BROVANA (arformoterol tartrate) Inhalation Solution.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider.

All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient. BROVANA is a medicine used to treat COPD. Remember that no medicine is for everyone. Only your doctor can prescribe BROVANA for you.

© 2009 Sepracor Inc. All Rights Reserved.